GASTROINTENSTINAL STROMAL TUMOR (GIST)
Clinical trials for GASTROINTENSTINAL STROMAL TUMOR (GIST) explained in plain language.
Never miss a new study
Get alerted when new GASTROINTENSTINAL STROMAL TUMOR (GIST) trials appear
Sign up with your email to follow new studies for GASTROINTENSTINAL STROMAL TUMOR (GIST), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Robots take on tricky stomach tumors: new safety trial launches
Disease control Recruiting nowThis study looks at how safe robotic surgery is for removing gastrointestinal stromal tumors (GISTs) located in hard-to-reach areas of the stomach. About 182 adults with small to medium tumors (2-5 cm) will have the robotic procedure. Researchers will track how many patients stay…
Matched conditions: GASTROINTENSTINAL STROMAL TUMOR (GIST)
Phase: NA • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Living longer with GIST: what are the hidden costs?
Knowledge-focused Recruiting nowThis study follows 330 adults with advanced or metastatic GIST who have been on targeted therapy (TKIs) for at least 2 years. Researchers will track quality of life, treatment side effects, and financial burdens over up to 10 years. The goal is to better understand the real-world…
Matched conditions: GASTROINTENSTINAL STROMAL TUMOR (GIST)
Sponsor: The Netherlands Cancer Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC